We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Depomed Decision Doesn’t Force FDA to Change Orphan Drug Program
Depomed Decision Doesn’t Force FDA to Change Orphan Drug Program
The FDA will maintain its policy on determining when an orphan drug product is entitled to market exclusivity, saying a recent federal court ruling that overruled the agency’s policy applied to just one drug and established no precedent.